Amelioration Mechanism Study of Simvastatin on Myocardial Collagen Changes After Myocardial Infarction in Rats
MA Kang-hu
Abstract
MA Kang-hu
Abstract
Objective:To investigate the beneficial effects of simvastatin on myocardial collagen changes in rats after myocardial infarction (MI) with its possible mechanisms. Methods:MI model was created by the ligation of left anterior descending coronary artery.24 hours after MI,the survival rats were randomly divided into three groups,MI group(n=9),Simvastatin 20 mg/(kg·d)treatment group(n=10),Simvastatin 40 mg/(kg·d) treatment group(n=9);meanwhile,the Sham-operation group(n=10) was established.After 4 weeks treatment, the effects of simvatatin on ventricular remodeling were evaluated by detecting the changes of left ventricular weight index (LVWI),the collagen volume fraction(CVF) in non-infarction zone(NIZ)was examined with Picric-Sirius Red Polarimetry,the expression of matrix metalloproteinase-2(MMP-2) by i mmunohistochemistry,and the expression of transforming growth factorβ1 (TGF-β1) in NIZ by RT-PCR and Western blot analysis.Meanwhile,the serum lipid levels were examined in all groups. Results:There were no significant changes among different groups for serum lipid levels(P0.05).Compared with Sham operation group,LVWI,typeⅠCVF,typeⅢCVF and theⅠ/Ⅲratio in NIZ were increased significantly in MI group.Compared with MI group,LVWI,typeⅠCVF,typeⅢCVF andⅠ/Ⅲratio in NIZ were decreased significantly in both of Simvastatin treatment groups,but higher than those in Sham operation group.In contrast with MI group,the expressions of MMP-2 and TGF-β1 were down regulated in both Simvastatin treatment groups,but higher than those in Sham operation group. Conclusion:Simvastatin could ameliorate MI induced myocardial collagen changes in rats,and this was independent of lipid regulation while it could be associated with down regulated MMP-2 and TGF-β1.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the beneficial effects of simvastatin on myocardial collagen changes in rats after myocardial infarction (MI) with its possible mechanisms. Methods:MI model was created by the ligation of left anterior descending coronary artery.24 hours after MI,the survival rats were randomly divided into three groups,MI group(n=9),Simvastatin 20 mg/(kg·d)treatment group(n=10),Simvastatin 40 mg/(kg·d) treatment group(n=9);meanwhile,the Sham-operation group(n=10) was established.After 4 weeks treatment, the effects of simvatatin on ventricular remodeling were evaluated by detecting the changes of left ventricular weight index (LVWI),the collagen volume fraction(CVF) in non-infarction zone(NIZ)was examined with Picric-Sirius Red Polarimetry,the expression of matrix metalloproteinase-2(MMP-2) by i mmunohistochemistry,and the expression of transforming growth factorβ1 (TGF-β1) in NIZ by RT-PCR and Western blot analysis.Meanwhile,the serum lipid levels were examined in all groups. Results:There were no significant changes among different groups for serum lipid levels(P0.05).Compared with Sham operation group,LVWI,typeⅠCVF,typeⅢCVF and theⅠ/Ⅲratio in NIZ were increased significantly in MI group.Compared with MI group,LVWI,typeⅠCVF,typeⅢCVF andⅠ/Ⅲratio in NIZ were decreased significantly in both of Simvastatin treatment groups,but higher than those in Sham operation group.In contrast with MI group,the expressions of MMP-2 and TGF-β1 were down regulated in both Simvastatin treatment groups,but higher than those in Sham operation group. Conclusion:Simvastatin could ameliorate MI induced myocardial collagen changes in rats,and this was independent of lipid regulation while it could be associated with down regulated MMP-2 and TGF-β1.
Key concepts: Simvastatin, Medicine, Myocardial infarction, Internal medicine, Ligation, Myocardial fibrosis, Cardiology, Endocrinology